Clinical Trial: A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Placebo-Controlled, Double-Blind Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects

Brief Summary: A study to determine the effect of Zemplar on the regulation of serum calcium levels and the need for administration of elemental calcium in hypocalcemic intensive care patients

Detailed Summary:
Sponsor: Abbott

Current Primary Outcome: The primary efficacy variable will be the change from Day 1 to last day of dosing in pH adjusted, serum ionized calcium levels.

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Abbott

Dates:
Date Received: January 27, 2003
Date Started: January 2002
Date Completion:
Last Updated: July 31, 2006
Last Verified: July 2006